COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,170 Articles (22,186 medRxiv, 7,984 bioRxiv)

Most recent first Previous |  Page 1367: Articles 13661-13670  | Next

The Impact of COVID-19 Vaccination on California's Return to Normalcy
Daza-Torres, M. L., Garcia Puerta, Y. E., Schmidt, A. J., Sharpnack, J. L., Pollock, B. H., Nuno, M. A.
10.1101/2021.06.01.21258187 — Posted: 2021-06-04
Aggregating probabilistic predictions of the safety, efficacy, and timing of a COVID-19 vaccine
McAndrew, T. C., Cambeiro, J., Besiroglu, T.
10.1101/2021.06.03.21258240 — Posted: 2021-06-04
A Prospective Observational Study to Investigate Performance of a Chest X-ray Artificial Intelligence Diagnostic Support Tool Across 12 U.S. Hospitals
Sun, J., Peng, L., Li, T., Adila, D., Zaiman, Z., Melton, G., Ingraham, N. E., Murray, E., Boley, D., Switzer, S., Burns, J. L., Huang, K., Allen, T., Steenburg, S. D., Wawira Gichoya, J., Kummerfeld, E., Tignanelli, C. J.
10.1101/2021.06.04.21258316 — Posted: 2021-06-04
Formation of oxidized gases and secondary organic aerosol from a commercial oxidant-generating electronic air cleaner
Joo, T., Rivera-Rios, J. C., Alvarado-Velez, D., Westgate, S., Ng, N. L.
10.1101/2021.06.01.21258186 — Posted: 2021-06-04
2020 SARS-CoV-2 diversification in the United States: Establishing a pre-vaccination baseline
Capoferri, A. A., Shao, W. A., Spindler, J., Coffin, J. M., Rausch, J. W., Kearney, M.
10.1101/2021.06.01.21258185 — Posted: 2021-06-04 Discussion: Onsite
Serial intervals observed in SARS-CoV-2 B.1.617.2 variant cases
Pung, R., Mak, T. M., CMMID COVID-19 Working Group, , Kucharski, A. J., Lee, V. J.
10.1101/2021.06.04.21258205 — Posted: 2021-06-04
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
Guerin, P. J., McLean, A. R. D., Rashan, S., Lawal, A. A., Watson, J. A., Nathalie Strub-Wourgaft, N., White, N. J.
10.1101/2021.06.04.21257852 — Posted: 2021-06-04
Comparing India's second COVID wave with the first wave, a single center experience
Kapoor, M., Singh, B. O., Panda, P. K., Dhangar, P., Kataria, A.
10.1101/2021.06.03.21258009 — Posted: 2021-06-04
Antibody profiling reveals gender differences in response to SARS-COVID-2 infection
Tsverava, L., Chitadze, N., Chanturia, G., Kekelidze, M., Dzneladze, D., Imnadze, P., Gamkrelidze, A., Lagani, V., Khuchua, Z., Solomonia, R.
10.1101/2021.06.01.21258175 — Posted: 2021-06-04
Genome-scale CRISPR Screens Identify Host Factors that Promote Human Coronavirus Infection
Grodzki, M., Bluhm, A. P., Schafer, M., Tagmount, A., Russo, M., Sobh, A., Rafiee, R., Vulpe, C. D., Karst, S. M., Norris, M. H.
10.1101/2021.06.04.447090 — Posted: 2021-06-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).